LENZ Therapeutics (LENZ) Earnings Date, Estimates & Call Transcripts → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free LENZ Stock Alerts $16.43 +0.25 (+1.55%) (As of 05/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Earnings SummaryLatest Earnings DateMay. 8ConfirmedConsensus EPS (May. 8) -$0.84 Listen to Call Get LENZ Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for LENZ and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLENZ Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LENZ Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. LENZ Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.74)($0.51)($0.63)Q2 20242($0.47)($0.46)($0.47)Q3 20242($0.46)($0.40)($0.43)Q4 20242($0.44)($0.42)($0.43)FY 20248($2.11)($1.79)($1.95)LENZ Earnings Date and InformationLENZ Therapeutics last announced its quarterly earnings data on May 8th, 2024. The reported $0.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.84) by $0.84. LENZ Therapeutics has generated ($15.61) earnings per share over the last year (($15.61) diluted earnings per share). Earnings for LENZ Therapeutics are expected to decrease in the coming year, from ($1.89) to ($2.46) per share. LENZ Therapeutics has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. LENZ Therapeutics will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More LENZ Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Confirmed)-($0.84)----- 11/13/2023Q3 2023($0.25)($0.19)+$0.06$0.01--8/14/2023Q2 2023($0.31)($0.31)-$0.35--5/11/2023Q1 2023($0.30)($0.38)($0.08)($0.33)--3/20/2023Q4 2022($0.51)($0.44)+$0.07($0.44)--11/9/2022Q3 2022($0.49)($0.45)+$0.04($0.45)--8/11/2022Q2 2022($0.49)($0.48)+$0.01($0.48)-- Get the Latest News and Ratings for LENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LENZ Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2022Q1 2022($0.36)($0.48)($0.12)($0.48)--3/21/2022Q4 2021($0.28)($0.35)($0.07)($0.35)--11/10/2021Q3 2021($0.28)($0.28)-($0.28)--8/12/2021Q2 2021($1.11)($3.45)($2.34)($3.45)-- LENZ Therapeutics Earnings - Frequently Asked Questions When is LENZ Therapeutics's earnings date? LENZ Therapeutics has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on LENZ's earnings history. Did LENZ Therapeutics beat their earnings estimates last quarter? In the previous quarter, LENZ Therapeutics (NASDAQ:LENZ) reported $0.00 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.84) by $0.84. Learn more on analysts' earnings estimate vs. LENZ's actual earnings. How can I listen to LENZ Therapeutics's earnings conference call? The conference call for LENZ Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How much profit does LENZ Therapeutics generate each year? LENZ Therapeutics (NASDAQ:LENZ) has a recorded net income of -$124.65 million. LENZ has generated -$15.61 earnings per share over the last four quarters. What is LENZ Therapeutics's EPS forecast for next year? LENZ Therapeutics's earnings are expected to decrease from ($1.89) per share to ($2.46) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Aligos Therapeutics Earnings Entera Bio Earnings Turnstone Biologics Earnings Cidara Therapeutics Earnings Ikena Oncology Earnings AVROBIO Earnings Elutia Earnings Precision BioSciences Earnings Instil Bio Earnings Athira Pharma Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:LENZ) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
